BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8112190)

  • 1. Decreased polymorphonuclear leukocyte deformability in NIDDM.
    Pécsvarády Z; Fisher TC; Darwin CH; Fabók A; Maqueda TS; Saad MF; Meiselman HJ
    Diabetes Care; 1994 Jan; 17(1):57-63. PubMed ID: 8112190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte membrane fluidity before and after activation in subjects with insulin resistance.
    Caimi G; Sinagra D; Canino B; Scarpitta AM; Montana M; Bonaventura V; Lo Presti R
    Acta Diabetol; 2000 Mar; 37(1):9-12. PubMed ID: 10928230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of granulocyte deformability following exposure to chemotactic stimuli.
    Pécsvárady Z; Fisher TC; Fabók A; Coates TD; Meiselman HJ
    Blood Cells; 1992; 18(2):333-52; discussion 353-8. PubMed ID: 1450430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phosphodiesterase (III/IV)-inhibitors and cytokines on mechanical properties of neutrophilic granulocytes in neonates and adults.
    Ruef P; Craciun E; Altfelder F; Simon C; Frommhold D; Koch L; Pöschl J
    Clin Hemorheol Microcirc; 2010; 45(2-4):301-10. PubMed ID: 20675913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of activators and the phosphodiesterase inhibitors pentoxifylline and enoximone on the deformability of neutrophils in neonates and adults.
    Ruef P; Poeschl JM; Simon C; Altfelder F; Craciun E; Linderkamp O
    Acta Paediatr; 2004 Oct; 93(10):1288-93. PubMed ID: 15499946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of polymorphonuclear leukocyte membrane fluidity: effect of cytoskeletal modification.
    Wiles ME; Dykens JA; Wright CD
    J Leukoc Biol; 1994 Aug; 56(2):192-9. PubMed ID: 7915297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Haffner SM; Agil A; Mykkanen L; Stern MP; Jialal I
    Diabetes Care; 1995 May; 18(5):646-53. PubMed ID: 8586002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheological response of neutrophils to different types of stimulation.
    Buttrum SM; Drost EM; MacNee W; Goffin E; Lockwood CM; Hatton R; Nash GB
    J Appl Physiol (1985); 1994 Oct; 77(4):1801-10. PubMed ID: 7836203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphonuclear leukocyte membrane fluidity, at baseline and after in vitro activation, in obesity with or without diabetes mellitus.
    Lo Presti R; Sinagra D; Montana M; Scarpitta AM; Catania A; Caimi G
    Acta Diabetol; 2002 Apr; 39(1):29-33. PubMed ID: 12043936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E1 inhibits N-formyl-methionyl-leucyl-phenylalanine-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin-induced forward light scatter changes.
    Fletcher MP
    J Immunol; 1987 Dec; 139(12):4167-73. PubMed ID: 3693900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway.
    Cassatella MA; Bazzoni F; Ceska M; Ferro I; Baggiolini M; Berton G
    J Immunol; 1992 May; 148(10):3216-20. PubMed ID: 1578146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic peptide-induced changes in neutrophil actin conformation.
    Wallace PJ; Wersto RP; Packman CH; Lichtman MA
    J Cell Biol; 1984 Sep; 99(3):1060-5. PubMed ID: 6470036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased rigidity and priming of polymorphonuclear leukocytes in sepsis.
    Drost EM; Kassabian G; Meiselman HJ; Gelmont D; Fisher TC
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1696-702. PubMed ID: 10351906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of hydrogen peroxide by neutrophilic polymorphonuclear leukocytes in patients with diabetic nephropathy.
    Watanabe A; Tomino Y; Yokoyama K; Koide H
    J Clin Lab Anal; 1993; 7(4):209-13. PubMed ID: 8360796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased deformability of polymorphonuclear leukocytes in diabetic cats.
    Braun RD; Fisher TC; Meiselman HJ; Hatchell DL
    Microcirculation; 1996 Sep; 3(3):271-8. PubMed ID: 8930884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movement of polymorphonuclear leukocytes: an elastimetry analysis.
    Cheung AT; Miller ME; Kawaoka EJ
    Biomater Med Devices Artif Organs; 1983; 11(1):53-61. PubMed ID: 6615997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional changes in aging polymorphonuclear leukocytes.
    Tanji-Matsuba K; van Eeden SF; Saito Y; Okazawa M; Klut ME; Hayashi S; Hogg JC
    Circulation; 1998 Jan 6-13; 97(1):91-8. PubMed ID: 9443436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating lipids and cardiovascular risk in newly diagnosed non-insulin-dependent diabetic subjects in India.
    Shelgikar KM; Naik SS; Khopkar M; Bhat DS; Raut KN; Joglekar CV; Gerard ME; Yajnik CS
    Diabet Med; 1997 Sep; 14(9):757-61. PubMed ID: 9300225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil F-actin and myosin but not microtubules functionally regulate transepithelial migration induced by interleukin 8 across a cultured intestinal epithelial monolayer.
    Hofman P; d'Andrea L; Guzman E; Selva E; Le Negrate G; Far DF; Lemichez E; Boquet P; Rossi B
    Eur Cytokine Netw; 1999 Jun; 10(2):227-36. PubMed ID: 10400829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cytochalasin B, N-formyl peptide and plasma on polarisation, zeiosis (blebbing) and degranulation of polymorphonuclear leukocytes in suspension.
    Bignold LP; Ferrante A
    Cell Biol Int Rep; 1988 Mar; 12(3):195-203. PubMed ID: 3383248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.